Overcome of resistance to therapy of maliganant gliomas by induction of autophagy
Overcome of resistance to therapy of maliganant gliomas by induction of autophagy
批准号:
21591866
负责人:
KURIMOTO Masanori
金额:
$2.83万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011
中文摘要
恶性胶质瘤细胞对化疗药物和放疗具有耐药性。对细胞凋亡的抵抗是这种治疗抵抗的主要机制。细胞程序性死亡的第二种机制,自噬是目前恶性胶质瘤细胞重要的细胞死亡过程。探讨了药物诱导恶性胶质瘤细胞自噬的可能性。抗凋亡药物和自噬诱导药物诱导胶质瘤细胞自噬。该策略可能是治疗恶性胶质瘤的一种新方法。
英文摘要
Malignant glioma cells are resisitant to chemothereutic agents and irradiation. The resistance to apoptosis is the main mechanism of this resistance to therapy. The second programmed cell death mechanism, autophagy is now important cell death process of malignant glioma cells. The authors investigated possibility of autophagy induction of malignant glioma cells by pharmaceutical methods. Antiapoptotic drugs and autophagy inducing drugs induced glioma cell autophagy. This strategy may be a novel therapeutic method of maliganat gliomas.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
グリオーマ幹細胞様細胞に対するトロンビンの効果
凝血酶对胶质瘤干细胞样细胞的影响
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Kawai Y, Umeda M, Watanabe Y, Higuchi T, Naruse S, Tanaka C, Sugiu K, 早川由美子]
通讯作者:
早川由美子
Basic research in molecular targeting therapy of malignant gliomas against NF-kB
-
批准号:15591513
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.79万
-
财政年份:2003
-
负责人:KURIMOTO Masanori
-
依托单位:
海外基金